Enlightenment of United States repackaged drugs supervision on China′s drug dismantling
WANG Huiling1 ZHUO Shengnan2 YUAN Dongdong3 LIU Wei2▲
1. School of Pharmacy, Zhengzhou Railway Vocational & Technical College
2. School of Pharmaceutical Sciences, Zhengzhou University
3. Department of Pharmacy, Zhengzhou Seventh People′s Hospital
Abstract：Dismounted drugs can reduce the burden of patients, waste and pollution of the environment. China lacks specific standards and requirements for the management of dismounted drugs, and there are more problems with dismounted drugs, mainly including substandard environmental hygiene, improper operation, non-standard packaging materials, and unclear methods of determining expiration dates. The United States regulatory policy for repackaged drugs is more complete, with clear provisions for packaging and storage environment, equipment and personnel hygiene,repackaging operations, packaging materials, principles of determining expiration dates, labeling information and repackaging records. It is recommended that the relevant regulatory authorities in China learn from the relevant policies of the United States repackaging regulation, establish a sound management system for dismounted drugs, promote medical institutions to provide quality pharmacy services, and protect the safety of patients′ medication.
王慧玲；卓胜男；袁冬冬；刘伟. 美国重新包装药品监管对我国药品拆零的启示[J]. 中国当代医药, 2022, 29(15): 139-142.
WANG Huiling； ZHUO Shengnan； YUAN Dongdong； LIU Wei. Enlightenment of United States repackaged drugs supervision on China′s drug dismantling. 中国当代医药, 2022, 29(15): 139-142.
Murdaugh Lb.Competence Assessment Tools for Health System Pharmacies[J].Ann Pharmacother，2003，37（11）：681-682.
[19]
Bachenheimer BS.Manual for Pharmacy Technicians[M].America：Oxford University Press，2010：401-429.
[17]
Mc Elhiney Lf.Unit-dose packaging and repackaging of solid and liquid dosage forms in an institutional setting[J].Int J Pharm Compd，2010，14（1）：32-38.
[20]
Okeke Cc，Bailey L，Medwick T，et al.Revised Usp Standards for Product Dating，Packaging，and Temperature Monitoring[J].Am J Health Syst Pharm，2000，57（15）：1441-1445.
[21]
Expiration Dating of Unit-Dose Repackaged Solid Oral Dosage Form Drug Products Guidance for Industry[S].2017.https://www.fda.gov/Drugs/Guidance Compliance Regulatory Information/Guidances/default.htm.
[22]
Thompson Ca.FDA Outlines Conditions for Pharmacies to Repackage Drug Products[J].Am J Health Syst Pharm，2017，74（7）：453-455.
[23]
United States Pharmacopeial Convention Inc.USP39-NF34[S].Rockille：The United States Pharmacopeial Convention press，2015：270-272，808-809.
[24]
Nguyen Rt，Sayeed Va.Repackaged Oral Dosage Forms：Beyond-use Dating and Product Safety Concerns[J].Am J Health Syst Pharm，2013，70（19）：1724-1727.
京公网安备 11010502046607号